Isoprinosine (Inosine Pranobex)

Inosine Pranobex acts by stimulating T‑cell proliferation and increasing interferon‑α production, which together boost the body’s antiviral defenses. It also enhances natural killer cell activity and promotes the release of cytokines, creating a broader immune response that can limit viral replication and spread.

The dosage of Isoprinosine is individualized by the prescribing clinician based on the specific indication, patient age, weight, and renal or hepatic function. Healthcare professionals determine the appropriate amount and schedule, and patients should follow the prescriber’s instructions without deviation.

Safety data for Isoprinosine during pregnancy and lactation are limited. It is generally classified as contraindicated or to be used only if the potential benefit justifies the potential risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives with their healthcare provider.

To order Isoprinosine, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

Compared with nucleoside analogues such as acyclovir, Isoprinosine does not directly inhibit viral DNA polymerase. Instead, it modulates the immune system, offering a broader antiviral effect that may be useful in infections where conventional antivirals have limited activity. Clinical choice depends on the virus, disease severity, and patient-specific factors.

Isoprinosine tablets should be stored at ambient temperature, preferably below 25 °C. Keep them in the original packaging to protect from moisture and direct sunlight. Do not store in damp areas or near heat sources, and keep out of reach of children.

Isoprinosine is administered orally, typically as a tablet that is swallowed with water. It is taken according to the schedule prescribed by the treating physician, which may involve multiple doses per day. Patients should not crush or chew the tablet unless specifically instructed.

Serious adverse events, although rare, include hematologic abnormalities such as leukopenia or thrombocytopenia, hepatic dysfunction indicated by elevated liver enzymes, and severe allergic reactions like anaphylaxis or angioedema. Patients should seek immediate medical attention if they experience unexplained bruising, jaundice, or signs of a severe allergic response.

Isoprinosine is contraindicated in individuals with known hypersensitivity to Inosine Pranobex or any excipients in the formulation. It should also be avoided in patients with severe immunodeficiency, uncontrolled hepatic or renal disease, and in pregnant or breastfeeding women unless the prescribing physician determines that the potential benefits outweigh the risks.